ubenimex has been researched along with transforming growth factor alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chojnowski, GM; Davern, CM; Ellem, KA; Francis, KG; Hall, PM; Piva, TJ | 1 |
| Cheng, YN; Cui, SX; Gao, JJ; Gao, ZH; Qu, XJ; Tang, W; Xu, WF; Xue, X | 1 |
1 review(s) available for ubenimex and transforming growth factor alpha
| Article | Year |
|---|---|
LYP, a bestatin dimethylaminoethyl ester, inhibited cancer angiogenesis both in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; CD13 Antigens; Cell Membrane; Endothelium, Vascular; Esters; Fibroblast Growth Factor 2; Humans; Leucine; Mice; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Transforming Growth Factor alpha; Umbilical Veins; Vascular Endothelial Growth Factor A | 2011 |
1 other study(ies) available for ubenimex and transforming growth factor alpha
| Article | Year |
|---|---|
Increased ecto-metallopeptidase activity in cells undergoing apoptosis.
Topics: Aminopeptidases; Apoptosis; Cell Membrane; Cisplatin; Cycloheximide; Dactinomycin; DNA Fragmentation; Flow Cytometry; HeLa Cells; Humans; Leucine; Metalloendopeptidases; Mutagens; Peptides; Protease Inhibitors; Transforming Growth Factor alpha; Ultraviolet Rays | 2000 |